New AIDS drug will be available in August

China's first domestically developed long-acting injectable AIDS drug will be available to the public in August, and is expected to benefit tens of thousands of people infected with HIV.

The drug, Albuvirtide, was recently approved by the State Drug Administration, according to a notice on the administration's website.

Developed by Nanjing-based Frontier Biotechnologies, the drug, which can be administered weekly, is said to be able to block the fusion of the virus and host cell membranes, interrupting the HIV life cycle in its earliest stage.